Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Calypte Biomedical Issues Statement.


BERKELEY, Calif.--(BW HealthWire)--June 1, 1998--In response to a news item that ran across the Associated Press Wire on June 1 at 16:25 EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
, Calypte Biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 Corporation issued the following statement as clarification:

"The FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 official quoted in the AP story was misleading in his characterization of the accuracy of the urine Western blot Western blot
A technique developed in 1979 that is used to confirm ELISA results. HIV antigen is purified by electrophoresis and attached by blotting to a nylon or nitrocellulose filter.
. The two individuals identified as having been 'missed' by the urine test were, in fact, undergoing anti-retroviral therapy for AIDS which has the effect of lowering the level of viral load and often the associated antibodies. The urine-only test system is intended to be used on individuals who do not know their HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  status. In addition, the story did not point out that, in a separate study of high-risk individuals, three samples that tested positive using the urine system had tested negative using a blood screening test. As further evidence of the urine test's importance as a public health tool, the journal Nature Medicine published an article inNovember 1997 which cited independent scientists who were able to use the urine test to isolate or identify HIV in two individuals that tested negative by the blood antibody test."

    CONTACT:  Healy Communication
               John Healy/Jason Sherman
               312/440-3900


COPYRIGHT 1998 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Article
Geographic Code:1USA
Date:Jun 1, 1998
Words:202
Previous Article:Sur American Gold Corp.: Complete Assay Results 3000 Metre Mina Rica Gold Project Drilling Program.
Next Article:Bishop Completes Private Placement and Option Grant.
Topics:



Related Articles
Calypte Biomedical and Cambridge Biotech complete urine Western blot submission.
Calypte reports first quarter results.
Published Study Provides New Understanding About HIV Infection and Significance of Urine HIV-1 Testing.
Calypte Founder Announces Formation of Genomics Venture.
Calypte Secures $25 Million Equity Financing Commitment.
Calypte Biomedical Raises up to $1.1 Million in Debenture Issuance.
Calypte's Alameda Manufacturing Facility Approved by FDA: Alameda Facility Will Allow Increased Production of HIV-1 Antibody Urine Test.
Calypte Reaffirms $25 Million Equity Financing Commitment; Company Amends Equity Line Facility and Files New Registration Statement with SEC.
Calypte's HIV-1 Serum Western Blot Assay to be Distributed by Organon-Teknika; Agreement Positions Calypte as a Major Manufacturer of Supplemental...
Calypte Completes Private Placement of $850,000 in Convertible Debentures and Obtains Additional Financing Commitment.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles